Abstract
Background
Despite being a long-term therapy for patients with short bowel syndrome (SBS), subcutaneous injections of teduglutide promote the regeneration of the gastrointestinal tract. Such cases are particularly concerning for patients with residual small bowel.
Methods
In this report, we present a case of an SBS patient with only 5 cm of remaining small bowel and a high-output duodenal stoma, who was treated with teduglutide.
Results
The initiation of teduglutide injections in our patient resulted in a reduction of stoma output, improvement in the patient’s nutritional status, regulation of fluid balance, and stabilization of their clinical condition.
Conclusions
This case suggests that subcutaneous injections of teduglutide, when combined with appropriate nutritional care, can effectively treat high-output stomas, even in cases where the small bowel is nearly absent.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pironi L, Cuerda C, Jeppesen PB, Joly F, Jonkers C, Krznaric Z, et al. ESPEN guideline on chronic intestinal failure in adults—update 2023. Clin Nutr. 2023;42:1940–2021. https://doi.org/10.1016/j.clnu.2023.07.019.
Kounatidis D, Vallianou NG, Tsilingiris D, Christodoulatos GS, Geladari E, Stratigou T, et al. Therapeutic potential of GLP-2 analogs in gastrointestinal disorders: current knowledge, nutritional aspects, and future perspectives. Curr Nutr Rep. 2022;11:618–42. https://doi.org/10.1007/s13668-022-00433-0.
Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O’Keefe SJ. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60:902–14. https://doi.org/10.1136/gut.2010.218271.
O’Keefe SJ, Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure. Clin Gastroenterol Hepatol. 2013;11:815–23.e811-813. https://doi.org/10.1016/j.cgh.2012.12.029.
Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O’Keefe SJ, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012;143:1473–81.e1473. https://doi.org/10.1053/j.gastro.2012.09.007.
Florencio Ojeda L, Dominguez Rabadan R, Lainez Lopez M, Jaldon Hidalgo G, Rodriguez Andres N, Penco Ramirez C, et al. Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: a case report. Nutrition. 2023;113:112137. https://doi.org/10.1016/j.nut.2023.112137.
Semmens S, Higgins E, Coyne P. A treatment for refractory high ileostomy output. J Pain Palliat Care Pharmacother. 2018;32:155–7. https://doi.org/10.1080/15360288.2018.1529011.
Nair A, Prasad A, Parikh S, Chaudhri M, Nookala V, Cheriyath P. A case report of cardiac failure in a patient on teduglutide for high-output ileostomy stoma. Cureus. 2023;15:e37518. https://doi.org/10.7759/cureus.37518.
Huo Z, Chong F, Yin L, Lu Z, Liu J, Xu H. Accuracy of the GLIM criteria for diagnosing malnutrition: a systematic review and meta-analysis. Clin Nutr. 2022;41:1208–17. https://doi.org/10.1016/j.clnu.2022.04.005.
Cederholm T, Jensen GL, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition—a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38:1–9. https://doi.org/10.1016/j.clnu.2018.08.002.
Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54:1224–31. https://doi.org/10.1136/gut.2004.061440.
Nightingale JM, Lennard-Jones JE, Walker ER, Farthing MJ. Jejunal efflux in short bowel syndrome. Lancet. 1990;336:765–8. https://doi.org/10.1016/0140-6736(90)93238-k.
Burness CB, McCormack PL. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome. Drugs. 2013;73:935–47. https://doi.org/10.1007/s40265-013-0070-y.
Author information
Authors and Affiliations
Contributions
AP, VV, and DK contributed to the acquisition and analysis of clinical data, participated in the literature review, and played a significant role in drafting and revising the manuscript; ZB, AP, KE, TA, and VV discussed and edited the manuscript. All authors have read and agreed to the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bouloubasi, Z., Karayiannis, D., Papadopoulou, A. et al. Managing fluid balance and nutritional status in a short bowel syndrome patient awaiting intestinal transplant: a case report. Eur J Clin Nutr (2024). https://doi.org/10.1038/s41430-024-01405-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41430-024-01405-z
